Cargando…

Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster

Detalles Bibliográficos
Autores principales: da Silva, Almir Ribeiro, Villas-Boas, Lucy Santos, de Paula, Anderson Vicente, Tozetto-Mendoza, Tania Regina, Honorato, Layla, Witkin, Steven S., Mendes-Correa, Maria Cassia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto de Medicina Tropical de São Paulo 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208660/
https://www.ncbi.nlm.nih.gov/pubmed/35730869
http://dx.doi.org/10.1590/S1678-9946202264043
_version_ 1784729771246092288
author da Silva, Almir Ribeiro
Villas-Boas, Lucy Santos
de Paula, Anderson Vicente
Tozetto-Mendoza, Tania Regina
Honorato, Layla
Witkin, Steven S.
Mendes-Correa, Maria Cassia
author_facet da Silva, Almir Ribeiro
Villas-Boas, Lucy Santos
de Paula, Anderson Vicente
Tozetto-Mendoza, Tania Regina
Honorato, Layla
Witkin, Steven S.
Mendes-Correa, Maria Cassia
author_sort da Silva, Almir Ribeiro
collection PubMed
description
format Online
Article
Text
id pubmed-9208660
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Instituto de Medicina Tropical de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-92086602022-07-01 Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster da Silva, Almir Ribeiro Villas-Boas, Lucy Santos de Paula, Anderson Vicente Tozetto-Mendoza, Tania Regina Honorato, Layla Witkin, Steven S. Mendes-Correa, Maria Cassia Rev Inst Med Trop Sao Paulo Letter to the Editor Instituto de Medicina Tropical de São Paulo 2022-06-17 /pmc/articles/PMC9208660/ /pubmed/35730869 http://dx.doi.org/10.1590/S1678-9946202264043 Text en https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
da Silva, Almir Ribeiro
Villas-Boas, Lucy Santos
de Paula, Anderson Vicente
Tozetto-Mendoza, Tania Regina
Honorato, Layla
Witkin, Steven S.
Mendes-Correa, Maria Cassia
Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster
title Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster
title_full Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster
title_fullStr Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster
title_full_unstemmed Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster
title_short Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster
title_sort neutralizing antibodies against the sars-cov-2 omicron variant following two coronavac vaccinations and a pfizer/biontech mrna vaccine booster
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208660/
https://www.ncbi.nlm.nih.gov/pubmed/35730869
http://dx.doi.org/10.1590/S1678-9946202264043
work_keys_str_mv AT dasilvaalmirribeiro neutralizingantibodiesagainstthesarscov2omicronvariantfollowingtwocoronavacvaccinationsandapfizerbiontechmrnavaccinebooster
AT villasboaslucysantos neutralizingantibodiesagainstthesarscov2omicronvariantfollowingtwocoronavacvaccinationsandapfizerbiontechmrnavaccinebooster
AT depaulaandersonvicente neutralizingantibodiesagainstthesarscov2omicronvariantfollowingtwocoronavacvaccinationsandapfizerbiontechmrnavaccinebooster
AT tozettomendozataniaregina neutralizingantibodiesagainstthesarscov2omicronvariantfollowingtwocoronavacvaccinationsandapfizerbiontechmrnavaccinebooster
AT honoratolayla neutralizingantibodiesagainstthesarscov2omicronvariantfollowingtwocoronavacvaccinationsandapfizerbiontechmrnavaccinebooster
AT witkinstevens neutralizingantibodiesagainstthesarscov2omicronvariantfollowingtwocoronavacvaccinationsandapfizerbiontechmrnavaccinebooster
AT mendescorreamariacassia neutralizingantibodiesagainstthesarscov2omicronvariantfollowingtwocoronavacvaccinationsandapfizerbiontechmrnavaccinebooster